Canadian Psychiatric Association

Editorial Credits/ Crédits éditorials

Subscription Rates /Prix d'abonnements

Advertising Rates / Tarifs publicitaires (PDF)

Guest Editorial
Imaging Brain Chemistry and Function in Neuropsychiatric Disorders
Peter C Williamson
PDF

In Review
In vivo Magnetic Resonance Spectroscopy and Its Application to Neuropsychiatric Disorders
Jeffrey A Stanley
PDF

Studies of Altered Social Cognition in Neuropsychiatric Disorders Using Functional Neuroimaging
Cheryl L Grady, Michelle L Keightley

PDF

Review Papers
Attention-Deficit Hyperactivity Disorder: Critical Appraisal of Extended Treatment Studies

Russell Schachar, Alejandro R Jadad, Mary Gauld, Michael Boyle, Lynda Booker, Anne Snider, Marie Kim, Charles Cunningham

PDF

Clinical Implications of a Link Between Fetal Alcohol Spectrum Disorder and Attention-Deficit Hyperactivity Disorder
Kieran D O'Malley, Jo Nanson

PDF

Original Research
Prescription Medication Use Among an Aboriginal Population Accessing Addiction Treatment

Dennis Wardman, Nadia Khan, Nady el-Guebaly

PDF

The Impact of Latitude on the Prevalence of Seasonal Depression
Anthony J Levitt, Michael H Boyle

PDF

Preliminary Assessment of Intrahemispheric QEEG Measures in Bipolar Mood Disorders
OJ Oluboka, SL Stewart, V Sharma, D Mazmanian, E Persad

PDF

Brief Communciation
Hepatic Adverse Reactions Associated With Nefazodone
Donna E Stewart

PDF


Book Reviews
(PDF - all reviews)

Functional Neuroimaging in Child Psychiatry

Handbook of Cultural Psychiatry

The Empathetic Healer: An Endangered Species?

Cognitive Rehabilitiation: An Integrative Neuropsychological Approach

The Madness of Adam and Eve: How Schizophrenia Shaped Humanity


Letters to the Editor
(PDF - all letters)

Evidence-Based Psychiatry

Evidence-Based Psychiatry: Response

Research Ethics and Forensic Psychiatry: A Comment on Regehr and Others

Research Ethics and Forensic Psychiatry: Response

Repetitive Transcranial Magnetic Stimulation is Useful for Maintenance Treatment

The Mood Disorder Questionnaire for Assessing Bipolar Spectrum Disorder Frequency

Capgras Syndrome and Blindness: Against the Prosopagnosia Hypothesis

Re: New Centry: Overcoming Stigma, Respecting Differences—Dr Myers' Superlative Presidential Address

Steroid-Induced Psychosis Treated With Risperidone

Studies of Altered Social Cognition in Neuropsychiatric Disorders Using Functional Neuroimaging



Autism

Altered social and emotional cognition in autism and in the related disorder of Asperger’s Syndrome (AS) have received the most attention in terms of neuroimaging. Hence, there is more information available in this group about how activity in the social network is disrupted. Consistent with behavioural studies showing that basic face perception is abnormal in individuals with autism (37), activity in the fusiform gyrus is reduced during face perception tasks involving neutral faces (38,39). Interestingly, activity in the lateral temporal cortex, which is thought to be more sensitive to nonface objects (40,41), is increased in autism patients compared with control subjects (39). Perception of emotion in faces is also impaired in autism (42,43), and activity in the amygdala during presentation of emotional faces is reduced (44). Autism patients, therefore, appear to have significant problems with aspects of face perception that are crucial to social cognition, along with deficits in activity of the brain regions that mediate these functions.

TOM in children with autism has been examined in several studies (45,46) and is generally impaired relative to normally developing children. Neuroimaging has been used to study TOM in adults with autism or AS in 2 experiments. Baron-Cohen and others (47) presented pictures of individuals’ eyes and had subjects judge either the sex of the person or the mental state expressed by the eyes (for example, “concerned”). Both the persons with autism and the control subjects had increased activity in the TOM task, compared with the sex task, in the left DLPFC and the bilateral STS. Control subjects had greater activity than did autism patients in the left amygdala and the VLPFC, whereas activity in the STS was greater in the patients. A second study by Happe and others used a different task, consisting of stories that required TOM to be interpreted correctly, contrasted with non-TOM stories (48). Patients with AS were examined in this experiment and were impaired on TOM performance and had reduced activity in a region of dorsomedial PFC that showed increased activity during TOM tasks in previous experiments (30,31). The patients did have activity in the medial PFC, but it was located ventrally to the region seen in control subjects, close to an area that has been found in at least 1 TOM study in normal individuals (29). Activity in STS regions did not differ between AS patients and control subjects. These experiments indicate that the areas activated by TOM tasks appear to be somewhat task-specific, but that prefrontal activity in autism and AS during TOM tasks is reduced, both in ventrolateral and in dorsomedial regions. In contrast, the areas of STS that are sensitive to gaze direction may be activated normally.

Other experiments on individuals with autism have not addressed social cognition directly but have provided information on some of the brain areas in the proposed network. One experiment scanned patients with autism and AS while they were performing a verbal memory task (49) and found that they had reduced activation in both the rostral and dorsal anterior cingulate regions, compared with a control group. Another study used an embedded figures test (50), in which the individuals with autism performed normally but, nevertheless, showed reduced activity in the right DLPFC. Further, the patients had greater activity in occipital areas, which is interesting in light of abnormally activated occipital activity during face tasks, mentioned above. Taken together, all these imaging experiments indicate that individuals with autism have dysfunction in almost all regions in the proposed social cognition network, mostly consisting of reduced activity. Note that these abnormalities have been found in high- functioning autism and AS patients, who clearly demonstrate these widespread changes, despite being less disabled than autism patients in general.


Schizophrenia

Despite the numerous studies describing impairments of social cognition in persons with schizophrenia, very few imaging studies have addressed any aspect of social cognition directly. TOM has been examined extensively in schizophrenia and is generally found to be impaired (51,52–58). Similarly, there is evidence that face processing is altered in persons with schizophrenia, both the processing of neutral faces (59) and the perception of emotional expressions on faces (60–62). There have been 3 imaging experiments reported using faces as stimuli, 2 that examined emotional processing, and 1 that examined TOM. In 1 of these experiments, face stimuli that express basic emotions were presented, and subjects carried out a sex-discrimination task (63). Subjects with schizophrenia differed from control subjects in several brain regions, depending on the emotion of the face. They showed less activation in the left VLPFC for angry faces and less activity in the amygdala for fearful faces. A second experiment examining emotion in schizophrenia used happy and sad faces to induce corresponding moods, with sex discrimination as the control task (64). During the mood task, patients showed less activation of the amygdala, as well as a reduced ability to recognize the face emotions, compared with control subjects. The TOM experiment (65) used the “eyes” task that was used for autistic patients (47). Schizophrenia patients made more errors on the task and showed less activation of the left VLPFC, compared with control subjects. Thus, schizophrenia, like autism, associates with deficits in emotional processing and TOM. In addition, it associates with reduced activity in the amygdala and in the VLPFC on tests of emotion and TOM derived from faces.

By far, most imaging studies of schizophrenia patients have focused on impaired working memory and altered activity in DLPFC, and work in this area has a long-standing history in the imaging field (66). Recently, several fMRI studies have examined this issue, most using a version of the n-back task, but sometimes with conflicting results. The n-back task is one in which a stream of stimuli are presented, and subjects are instructed to respond to a stimulus if it was presented 1 or 2 back in the sequence. In one such experiment, Callicott and others used 0-, 1-, and 2-back tasks, with visually presented digits, in both schizophrenia and control subjects (67). Both groups showed an increase in prefrontal and parietal activity with increasing task load, but this increase was larger in parietal cortex in the control subjects and larger in the right DLPFC in schizophrenia patients. In addition, this right PFC activity was correlated positively with performance in control subjects but correlated negatively in the patients, suggesting an inefficiency of cortical response in this region. Perlstein and others reported a similar experiment using 0-, 1-, and 2-back tasks with letters. In this study, however, schizophrenia patients showed a smaller increase in right DLPFC activity, with increasing task load compared with the control subjects. Correlations with performance were not reported, but severity of disorganization symptoms in the patients correlated with signal change in the right DLPFC, such that more severe symptoms were associated with smaller signal changes.

 

Meyer-Lindenberg and colleagues (69) and Menon and others (70), who used an auditory 2-back task, reported similar results of decreased DLPFC activity during n-back tasks in schizophrenia. The study by Menon also reported a negative correlation between severity-of-thought disorder and activity in the right DLPFC, similar to that found by Perlstein and others. Finally, Manoach and colleagues used a different working memory paradigm, known as the Sternberg task, in schizophrenia patients (71). This task involved presenting a set of stimuli that, in this case, included sets of 2 or 5 digits followed by a probe stimulus; the subject’s task was to decide whether the probe was part of the presented set. The patients showed more activation in the left DLPFC during the 5-digit task, and increases in this region were correlated with better performance on the task, unlike the finding of Callicott and others. The results of these experiments make clear that activity in the DLPFC is altered in individuals with schizophrenia and is related both to their memory ability and to symptom severity, but the direction of change in patients may be somewhat task-specific. Other factors are most likely involved, as well, and these are discussed in the final section.

Two additional studies used an attentional function test in schizophrenia patients, known as the continuous performance test (CPT). In 1 of these, first-episode patients had reduced activity in the left DLPFC, similar to that found in some of the working memory tasks discussed above (72). However, unlike the typical working memory task where schizophrenia patients show reduced performance, the patients in this study did not show a behavioural deficit on the CPT. The second attentional experiment degraded the letter stimuli in a CPT task to increase the number of errors committed by the participants. Control subjects showed increased activity in the dorsal cingulate on error trials and slowed response times, indicating increased demand on performance monitoring. Persons with schizophrenia had significantly reduced activity in the cingulate and failed to show the effect on reaction times, suggesting a failure of self-monitoring in these patients. Thus, schizophrenia patients show altered activation of several regions in the social cognition network—including the amygdala, the dorsal cingulate, and the VLPFC—but the most marked differences are found in the DLPFC.


Depression

Most neuroimaging depression studies have been carried out on patients at rest. General findings have indicated abnormal blood flow and glucose metabolism in several regions relevant to social cognition, including the amygdala, the rostral anterior cingulate, the orbitofrontal cortex, and the DLPFC (73). Typically, areas involved in higher cognitive function (for example, the DLPFC) are deactivated, while structures mediating emotional and stress responses (for example, the amygdala) are abnormally activated. Drevets has suggested that increased activity in the amygdala may reflect stimulation of cortical structures involved in declarative memory, thus accounting for the tendency of subjects with depression to “ruminate” about particular emotionally negative memories (74). Ventromedial prefrontal regions also have increased metabolic activity during rest in subjects with depression, and subgenual cingulate metabolism is related both to depression severity and autonomic changes (75). There is evidence that the rostral cingulate may play a critical role in recovery from depression. Patients responding to treatment are reported to show higher activity in the rostral cingulate, compared with a control group, whereas nonresponders were hypometabolic relative to control subjects (76).

Depression, therefore, appears to associate with abnormal functioning in both higher cognitive and limbic domains. This suggests that the phenomenology of depression might not be the result of the functional irregularity of isolated regions but a malfunction in the regulation of an entire network of regions involved in emotional behaviour. A limbic-cortical dysregulation model has been proposed to account for the pathophysiology of depression (77). Increased blood flow to ventral paralimbic regions is thought to reflect the vegetative-somatic symptoms associated with the disorder, while decreased blood flow in dorsal neocortical areas characterizes compromised cognitive function and attention capacity. There is further evidence that an imbalance between the subgenual cingulate and the DLPFC is critical to the dysregulation of mood and cognition in depression (78).

Several studies have examined perception of emotional stimuli in depression patients. Sheline and others presented masked emotional and neutral faces to healthy control subjects and subjects with depression during a fMRI study (79). Subjects with depression demonstrated an exaggerated left amygdala response to all faces, which was significantly greater for fearful faces, compared with healthy control subjects. After treatment with sertraline (a selective serotonin reuptake inhibitor), patients showed reduced activity in the amygdala bilaterally to all faces, most notably fearful faces, whereas there was no difference between scanning sessions for control subjects (who were drug-free for both scans). Similar results were reported by Yurgelun-Todd and colleagues (80), who found increased amygdalar response to fearful faces in patients with bipolar affective disorder, and by Drevets (74), who found greater amygdala activity during presentation of sad faces in depression patients.

In addition, studies of mood induction have been fruitful in understanding the neural mechanisms of depression. Mayberg and others examined mood provocation techniques in healthy women to isolate specific brain regions associated with sad-mood states (78). The mood-induction paradigm required participants to prepare a script of a sad autobiographical memory, and when the script was presented, subjects were instructed to feel the sadness associated with that memory, but not to ruminate or think about the event. During sadness, activity decreased in the right DLPFC and in the dorsal anterior cingulate, but increased in the subgenual anterior cingulate and the insula. Resting data from depression patients who responded to treatment with fluoxetine were compared with these changes associated with induced sadness in the healthy subjects. The posttreatment scans in the patients, compared with those obtained prior to treatment, showed changes in the same regions as in healthy volunteers, when experiencing transient sadness; however, the direction of change was reversed. That is, remission of depression was associated with metabolic increases in the DLPFC and dorsal anterior cingulate and decreases in the subgenual cingulate and the insula. These results show that sad mood associates with a specific pattern of changes in the limbic and cortical regions—areas that are altered in depression— and that resolution of negative mood symptoms in depressive illness results in a normalization of this pattern.

A mood-induction study comparing remitted depression and acute depression patients showed similar mood-related changes in the 2 groups, except for the rostral cingulate (81). Decreased activity in this region in the remitted group, increased activity in the acutely ill patients, and no changes in a control group suggests that this region may play a unique role in mediating emotional health. A final mood-induction fMRI study used a film clip to induce sad mood in depression patients and found significantly greater activity in the dorsomedial PFC and in the dorsal anterior cingulate gyrus in depression patients vs control subjects, but no difference in the average subjective ratings of sadness (82).